Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate

Journal of Microencapsulation

Volumn 28, Issue 7, 2011, Pages 650-658

  Gelfuso, Guilherme Martins ^a   Gratieri, Tas ^a   Simáo, Patrcia Sper ^a   De Freitas, Luís Alexandre Pedro ^a   Lopez, Renata Fonseca Vianna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alopecia; Chitosan; Follicular delivery; Microparticles; Minoxidil sulphate; Topical delivery

Indexed keywords

ALCOHOL; CHITOSAN; MINOXIDIL; MINOXIDIL SULFATE; POLYMER; WATER;

ALOPECIA; ARTICLE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; HUMAN; HUMAN CELL; MICROENCAPSULATION; MICROPARTICLE; PARTICLE SIZE; POROSITY; SPRAY DRYING; SWELLING;

ADMINISTRATION, TOPICAL; CHITOSAN; DRUG DELIVERY SYSTEMS; HUMANS; MICROSPHERES; MINOXIDIL; NANOPARTICLES; PARTICLE SIZE; VASODILATOR AGENTS;

EID: 80053414428     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2011.604435     Document Type: Article

References (31)

1. Bitz C, Doelker E. Influence of the preparation method on residual solvents in biodegradable microspheres. Int J Pharm, 1996;131:171-81. (Pubitemid 26144952)
2. Bienová M, Kucerová R, Fiurasková M, Hajdúch M, Kolár Z. Androgenic alopecia and current methods of treatment. Acta Dermatovenerol Alp, 2005;14:5-8. (Pubitemid 40469914)
3. Buhl AE, Waldon, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol, 1990;95:533-7.
4. Cevher E, Orhan Z, Mülazimoǧlu L, Sensoy D, Alper M, Yildiz A, Ozsoy Y. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. Int J Pharm, 2006;317:127-35.
5. De Jalon EG, Blanco-Prieto MJ, Ygartua P, Santoyo S. PLGA microparticles: possible vehicles for topical drug delivery. Int J Pharm, 2001;226:181-4. (Pubitemid 32800792)
6. De Santana DC, Pupo TT, Sauaia MG, da Silva RS, Lopez RF. Nitric oxide photorelease from hydrogels and from skin containing a nitroruthenium complex. Int J Pharm, 2010;391:218.
7. FDA (U.S. Food and Drug Administration) Guidance for industry: analytical procedures and methods validation. 2000. Available at: http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM122858.pdf (accessed 12 September 2009).
8. Gao F, Kodama T, Chen X, Okada K, Honda T. A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells. J Drug Target, 2007;15:428-36. (Pubitemid 47073058)
9. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm, 2008;69:1-9. (Pubitemid 351467152)
10. Gavini E, Rassu G, Muzzarelli C, Cossu M, Giunchedi P. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. Eur J Pharm Biopharm, 2008;68:245-52.
11. Gelfuso GM, Figueiredo FV, Gratieri T, Lopez RF. The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). J Pharm Sci, 2008;97:4249-57.
12. Gelfuso GM, Gratieri T, Souza JG, Thomazine JA, Lopez RF. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. Eur J Pharm Biopharm, 2011;77:249-56.
13. Gribanov AV, Sazanov YN. Polyacrylonitrile: carbonization problems. Russ J Appl Chem, 2008;81:919-32.
14. Higuchi WI. Analysis of data on medicament release from ointments. J Pharm Sci, 1962;51:802.
15. Intra J, Salem AK. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells. J Drug Target, 2010 [Epub ahead of print].
16. Ji JJ, Ding ZJ, Yang XL. Preparation and properties of chitosan film as a drug sustained-release system. West China Journal of Stomatology, 2009;27:248-51.
17. Lopez RF, Seto JE, Blankschtein D, Langer R. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials, 2011;32:933-41.
18. Meidan VM, Bonner MC, Michiniak BB. Transfollicular drug delivery-is it a reality?. Int J Pharm, 2005;306:1-14.
19. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol, 2004;150:186-94. (Pubitemid 38352454)
20. Münster U, Nakamura C, Haberland A, Jores K, Mehnert W, Rummel S, Schaller M, Korting HC, Zouboulis ChC, Blume-Peytavi U, et al. Ru 58841-myristate-prodrug development for topical treatment of acneand androgenetic alopecia. Pharmazie, 2005;60:8-12.
21. Nafee N, Taetz S, Schneider M, Schaefer UF, Lehr CM. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomedicine, 2007;3:173-83. (Pubitemid 47332344)
22. Oliveira BF, De Santana MHA, Ré MI. Spray-dried chitosan microspheres as a pDNA carrier. Drying Technol, 2006;24:373-82.
23. Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(D,L-lactide-co- glycolide) microspheres containing 5-fluorouracil: optimization of process parameters. AAPS PharmSciTech, 2003;4:E13.
24. Pitaksuteepong T, Somsiri A, Waranuch N. Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles. Eur J Pharm Biopharm, 2007;67:639-45. (Pubitemid 47576604)
25. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, Wurm EM, Yoong C, Robertson TA, Soyer HP, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Del Rev, 2011 [Epub ahead of print].
26. Shah PP, Mashru RC, Thakkar AR, Badhan AC. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology. J Pharm Pharmacol, 2008;60:421-7. (Pubitemid 351500552)
27. Shim J, Seok H, Shim J, Seok Kang H, Park WS, Han SH, Kim J, Chang IS. Transdermal delivery of minoxidil with block copolymer nanoparticles. J Control Release, 2004;97:477-84. (Pubitemid 38802949)
28. Smijs TG, Bouwstra JA. Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. J Biom Nanotechnol, 2010;6:469-84.
29. Tran V-T, Benoît J-P, Venier-Julienne M-C. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy?. Int J Pharm, 2011;407:1-11.
30. Toll R, Jacobi U, Richter H, Ladermann J, Schaefer H, Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol, 2004;123:168-76. (Pubitemid 38833478)
31. Wu X, Landfester K, Musyanovych A, Guy RH. Disposition of charged nanoparticles after their topical application to the skin. Skin Pharmacol Physiol, 2010;23:117-23.